BioChain Services, Inc is the first commerical provider to offer the complete selection of xenograft models, which includes classical xenograft (from cancer cell lines), Living Tumor TM xenograft (from human tissue) and immuno-competent xenograft. With all these xenograft services, we are offering unique opportunities for our client to test anti-cancer drug on a variety of oncology-related studies.

BioChain Services also provide reagents and assay services for in vitro or in vivo angiogenesis assays, include soft agar gel assays, various tube-formation assays, wound healing assays, migration assays etc.